Highbridge Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,849
| Closed | -$458K | – | 678 |
|
|
2018
Q1 | $458K | Sell |
9,849
-294,981
| -97% | -$13.7M | 0.01% | 539 |
|
|
2017
Q4 | $11.5M | Sell |
304,830
-81,414
| -21% | -$3.06M | 0.2% | 111 |
|
|
2017
Q3 | $14.1M | Buy |
+386,244
| New | +$14.1M | 0.21% | 101 |
|
|
2017
Q2 | – | Sell |
-200,829
| Closed | -$6.3M | – | 944 |
|
|
2017
Q1 | $6.3M | Buy |
+200,829
| New | +$6.3M | 0.09% | 227 |
|
|
2016
Q3 | – | Sell |
-37,896
| Closed | -$1.26M | – | 1100 |
|
|
2016
Q2 | $1.26M | Sell |
37,896
-2,607
| -6% | -$86.7K | 0.02% | 447 |
|
|
2016
Q1 | $1.19M | Sell |
40,503
-3,867
| -9% | -$114K | 0.02% | 401 |
|
|
2015
Q4 | $1.17M | Buy |
+44,370
| New | +$1.17M | 0.02% | 433 |
|
|
2015
Q2 | – | Sell |
-100,878
| Closed | -$2.4M | – | 898 |
|
|
2015
Q1 | $2.4M | Sell |
100,878
-655,530
| -87% | -$15.6M | 0.03% | 376 |
|
|
2014
Q4 | $16.1M | Sell |
756,408
-1,710,780
| -69% | -$36.3M | 0.21% | 141 |
|
|
2014
Q3 | $42M | Buy |
2,467,188
+2,238,720
| +980% | +$38.1M | 0.55% | 38 |
|
|
2014
Q2 | $3.27M | Buy |
+228,468
| New | +$3.27M | 0.04% | 277 |
|
|
2014
Q1 | – | Sell |
-1,976,334
| Closed | -$21.7M | – | 764 |
|
|
2013
Q4 | $21.7M | Buy |
1,976,334
+1,178,760
| +148% | +$12.9M | 0.26% | 116 |
|
|
2013
Q3 | $9.26M | Buy |
+797,574
| New | +$9.26M | 0.1% | 238 |
|